Interview: BioNTech And Pfizer Explore mRNA Flu Vaccines In $120m+ Deal

 
• By Kevin Grogan

The German biotech's CBO and CCO Sean Marett tells Scrip that the Pfizer pact represents the first time BioNTech has moved into infectious disease in humans and could lead to higher potency flu vaccines that could be made more rapidly and cheaply.

Cash injection
BioNTech gets Pfizer cash injection for flu vaccine • Source: Shutterstock

More from Anti-infective

More from Therapy Areas